Wordt geladen...
Future prospects for contact factors as therapeutic targets
Anticoagulants currently used in clinical practice to treat or prevent thromboembolic disease are effective, but place patients at increased risk for serious bleeding because they interfere with plasma enzymes (thrombin and factor Xa) that are essential for hemostasis. In the past 10 years, work wit...
Bewaard in:
| Gepubliceerd in: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4364029/ https://ncbi.nlm.nih.gov/pubmed/25696834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/asheducation-2014.1.52 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|